Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Devil`s Advocate

RE: Devil`s Advocate

posted on Apr 05, 2006 07:42AM
Ok, I missed one...Royalties.....not reoccuring type.

Let`s argue that there is not reoocuring type.

(I say so what, here is my thought....as quoted from the PR:

``the co-owner of what our advisors tell us is a highly valuable patent portfolio of ubiquitous high-tech intellectual property.`` Don`t you think them so called Advisors will be able to come to some sort of $ figure for each company that will not let them get away with murder so to speak, unless used for bait..like a early birth good deal. Makes good sense to me.

OK, reoccuring type....well these advisors can look at a company and make up their mind who needs to pay over time or who can pay up front, and even both....We don`t know what payments are for what, some upfront type could be only for past sins only. We don`t know how they are evaluating companies.

Devil`s Advocate response to to say no reoccuring type royalties ever.

( I say so what, even it that is true, (and I think we may get to that with some big fish (pun)) giving the ones now one time payments will work to our benifit and even if all pay one timmers, well we will take in a boat loat of cash..LOL

Looks good to me.

Share
New Message
Please login to post a reply